Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Childhood Leukemia, Acute Lymphoblastic”

866 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 866 results

Testing effectiveness (Phase 2)Study completedNCT00057811
What this trial is testing

Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Diffuse Large Cell LymphomaChildhood Immunoblastic Large Cell Lymphoma+9 more
Children's Oncology Group 97
Not applicableStudy completedNCT00330538
What this trial is testing

Osteoporosis in Children With ALL

Who this might be right for
Leukemia, Lymphocytic, Acute, L1
Children's Mercy Hospital Kansas City 20
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Testing effectiveness (Phase 2)Ended earlyNCT00555048
What this trial is testing

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 1
Early research (Phase 1)Looking for participantsNCT04881240
What this trial is testing

Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia, RefractoryPediatric ALL
St. Jude Children's Research Hospital 60
Early research (Phase 1)Study completedNCT00376480
What this trial is testing

Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Dana-Farber Cancer Institute 19
Not applicableLooking for participantsNCT04794296
What this trial is testing

Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP

Who this might be right for
Childhood ALL
French Africa Pediatric Oncology Group 500
Not applicableUnknownNCT05639673
What this trial is testing

Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Rigshospitalet, Denmark 5,000
Testing effectiveness (Phase 2)Study completedNCT01445080
What this trial is testing

Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

Who this might be right for
Blastic PhaseChildhood Acute Promyelocytic Leukemia With PML-RARAChildhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive+7 more
National Cancer Institute (NCI) 70
Large-scale testing (Phase 3)Study completedNCT00005596
What this trial is testing

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 1,076
Not applicableStudy completedNCT00898872
What this trial is testing

SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial

Who this might be right for
Lymphoma
SWOG Cancer Research Network 32
Early research (Phase 1)Temporarily pausedNCT00077493
What this trial is testing

BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
MedImmune LLC 95
Not applicableStudy completedNCT00899899
What this trial is testing

Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission

Who this might be right for
Leukemia
Children's Oncology Group 135
Testing effectiveness (Phase 2)Study completedNCT00003406
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Cancer Treatment Centers of America 30
Large-scale testing (Phase 3)Study completedNCT00075725
What this trial is testing

Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic LeukemiaChildhood B Acute Lymphoblastic Leukemia
Children's Oncology Group 3,154
Not applicableUnknownNCT00526084
What this trial is testing

Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in Taiwan

Who this might be right for
Leukemia, Lymphocytic, Acute
National Taiwan University Hospital 500
Testing effectiveness (Phase 2)Study completedNCT01177371
What this trial is testing

High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more
Case Comprehensive Cancer Center 13
Testing effectiveness (Phase 2)UnknownNCT03265106
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma Subjects

Who this might be right for
Relapsed B-cell Acute Lymphoblastic Leukemia, ChildhoodRefractory B-cell Acute Lymphoblastic Leukemia, ChildhoodRelapsed/Refractory B-cell Lymphoma, Childhood
Shenzhen BinDeBio Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT04562792
What this trial is testing

Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia

Who this might be right for
Relapsed Pediatric ALLRelapsed Pediatric AMLRefractory Acute Myeloid Leukemia+1 more
Children's Mercy Hospital Kansas City 1
Early research (Phase 1)Study completedNCT00462787
What this trial is testing

Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center 23
Load More Results